共 50 条
- [32] Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trial DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 501 - 511
- [33] Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (03): : 567 - 574